Pandemic preparedness and vaccine trials
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- MINISTRY OF HEALTH
Israel's national health authority coordinating transnational research funding in rare diseases, AMR, neuroscience, and personalized medicine through ERA-NET mechanisms.
“Joined VACCELERATE (EUR 224K) as part of Europe's COVID-19 clinical vaccine trial accelerator platform, their first direct involvement in pandemic response infrastructure.”
IL22 projects - BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA
Slovak Academy biomedical center specializing in virus archives, tick-borne pathogen research, and microfluidic cancer diagnostics across European consortia.
“Contributed to VACCELERATE (COVID-19 vaccine trial platform) and EVA-GLOBAL which pivoted to pandemic response support.”
SK9 projects - HACETTEPE UNIVERSITESI
Turkish research university strong in rare diseases, pandemic response, and clinical trials, expanding into AI-driven medical imaging and digital health.
“Contributed to EU-RESPONSE (pandemic preparedness platform trials) and VACCELERATE (European COVID-19 vaccine trial accelerator with site mapping and capacity building).”
PrimaryTR8 projects